Breast Cancer

Ibrance gained full FDA approval for the treatment of some patients with breast cancer.

A debate among health care providers has ensued over the cardiotoxicity risk that is associated with anthracycline regimens for patients with breast cancer. Sara A. Hurvitz, M.D., weighs in.

Some patients experience fatigue as a side effect of cancer treatment. And for some of us, fatigue lingers on and on and on.

How does one heal after a cancer diagnosis?

Mohammad Jahanzeb, M.D., discusses the SystHERs study, which is looking closely at current treatment methods for HER2- positive metastatic breast cancer (MBC).

Choosing a prosthesis requires a little work on the part of the wearer. Understanding options is not only helpful, but necessary.

What about hope? Don’t kill hope. Breast cancer and melanoma survivor shares what helped at the time of diagnosis and early on in her cancer treatment.

Adam M. Brufsky, M.D., Ph.D., discusses bone-targeted agents in breast cancer, and what we can expect for the future of this kind of therapy.

Women with breast cancer who were treated with AIs may experience sexual side effects, but there are steps that can be taken to improve their quality of life.

Michael F. Press, M.D., Ph.D., shed light on the role of the receptor in breast cancer in a presentation during the 2017 Miami Breast Cancer Conference.

How do you educate people about a cancer so rare that just one percent of the cancer population has it?

Patrick I. Borgen, M.D., discusses new discoveries that could lead to better, more individualized treatment for men with breast cancer.

Breast implants, especially those with textured surfaces, may be associated with a rare type of lymphoma, according to a recent statement by the Food and Drug Administration (FDA).

Sara Hurvitz, M.D. talks about recent and upcoming advancements in the treatment of HER2-positive breast cancer

Treatment is over -- no longer are days filled with doctors' appointments, choices, planning and cancer

Dry brushing helps exfoliate skin, but can it also stimulate the lymphatic system?

Surviving cancer has a hidden side to be reckoned with.

Watching current health care debates, we need to take deep breaths and trust that intelligent, compassionate people will make responsible choices affecting a nation. Writing letters to support our choices can help.

When breast cancer patients are misclassified by subtype, it can mean the best treatment options are delayed.

Neoadjuvant treatment may decrease the amount of surgery some women with breast cancer need to have, says Debu Tripathy, M.D.

You readily see the physical changes caused by cancer, but what goes on in your mind is just as noteworthy.

There are times when talking to another cancer patient, someone just like you, could be the key to better coping and a better life with this disease. Join a conversation, make a call, go online to make a positive change.

Jubilee Brown, M.D., obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.

Receiving a diagnosis of NED (no evidence of disease) is reason for celebration!

Breast cancer and melanoma survivor says you are allowed to feel what you are feeling, whatever that is.

New guidelines may result in a small percentage of patients with breast cancer being misclassified and not receiving proper treatment, Michael F. Press, M.D., Ph.D., says.

Only in a family like mine, where breast cancer comes up fairly often, would my daughter Kirtley call me into the bathroom to see a pimple on her breast at age 14.

Kisqali (ribociclib), a CDK 4/6 inhibitor, gained approval from the Food and Drug Administration (FDA) for the frontline treatment of postmenopausal women with hormone-receptor (HR)–positive, HER2-negative advanced breast cancer.

I’m lying there with the machines swirling around me, staring up at a faux light, and literally, it was as if the clouds started moving. And I thought ‘Would be great to have a lemonade right now.’” - Apryl Allen